Plans for a £1bn expansion of the London Cancer Hub, led by Aviva Capital Partners and development manager Socius, have received consent from Sutton Council.

The approved scheme will deliver around 1m sq ft of state-of-the-art laboratory and research space across 12 acres and is expected to create 3,000 new jobs, the majority in high-skilled R&D and life sciences-related manufacturing.

Sophie White, Sector Head Regeneration at Aviva Capital Partners, said: "We’re delighted to secure planning consent for the London Cancer Hub - a landmark moment for this scheme. This development will deliver critical science infrastructure for the UK, helping the UK get ready for the future by creating an environment where innovation can flourish and lifesaving research can accelerate. We are proud to play a role in shaping a campus that will have a profound impact on global health, as well as the economy."

The new buildings will target net-zero carbon in operation and deliver the amenities and public realm expected of a world-leading employment district, including affordable homes for approximately 220 key workers and new public spaces designed to support wellbeing, collaboration and community.

Recognised in the Mayor of London’s Growth Plan as a key engine for frontier innovation, the project will deliver significant economic benefits, creating high-skilled jobs and drawing international investment into the UK’s life sciences sector.